Jump to content

The Anti-Munchies Drug


catbirdseat

Recommended Posts

A new drug being developed by Sanofi-Synthelabo called rimonabant works by blocking the same receptors in the brain that are activated by cannabinoids when you smoking pot. It was shown to be effective in smoking cessation and in weight loss, especially in the waist, or so-called "visceral fat". This is going to be a gold mine for Sanofi. Now is the time to buy some stock in the company. This is going to be the greatest thing since sliced bread.

Link to comment
Share on other sites

  • Replies 10
  • Created
  • Last Reply

Top Posters In This Topic

This isn't insider information. The payoff, if there is one, would only come in about two years when the final results of the phase III clinical trials are made public. So here's my take. The phase II trials are large enough to show significant efficacy. The phase III trials will reveal if there are any relatively rare side effects. If it looks good, I'd say this is a drug worth $2-4 billion a year.

Link to comment
Share on other sites

  • 8 months later...

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.




×
×
  • Create New...